{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "In a decision that has forced the cancellation of at least 10 research projects, a New York State appeals court has found the state's rules governing psychiatric experiments on children and the mentally ill to be unconstitutional. The court found that the rules did not adequately protect people who, because of age or illness, cannot give informed consent to take part in drug tests or other experiments.", "headline": {"main": "New York Court Order Halts Some Research in Psychiatry"}, "abstract": "At least ten research projects have been cancelled in New York as result of appeals court finding that state's rules governing psychiatric experiments on children and the mentally ill are unconstitutional because participants cannot give informed consent; December 5 ruling focused on experiments that might pose health risk without direct benefit to patient; ruling may well set precedent elsewhere; researchers say they are otherwise unable to test drugs for severe mental illness or Alzheimer's disease; state has allowed consent by 'surrogates,' not necessarily parent or legal guardian; Federal rules are stricter; Judge David Ross's ruling quoted (M)", "print_page": "1", "word_count": 1546, "_id": "4fd1dadc8eb7c8105d71b131", "snippet": "In a decision that has forced the cancellation of at least 10 research projects, a New York State appeals court has found the state's rules governing psychiatric experiments on children and the mentally ill to be unconstitutional.    The court found...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/12/27/nyregion/new-york-court-order-halts-some-research-in-psychiatry.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ROSS, DAVID"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "subject", "value": "STANDARDS AND STANDARDIZATION"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "DECISIONS AND VERDICTS"}], "byline": {"person": [{"firstname": "Philip", "middlename": "J.", "lastname": "HILTS", "rank": 1, "role": "reported", "organization": ""}], "original": "By PHILIP J. HILTS"}, "document_type": "article", "pub_date": "1996-12-27T00:00:00Z", "section_name": "Front Page; Health; New York and Region"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "Very few consumers of prescription drugs are aware of the existence of pharmaceutical benefit managers, the large and increasingly powerful companies that handle the purchase and distribution of prescription drugs for many H.M.O.'s and insurance companies. In their zeal to enhance profits, the benefit managers, known as P.B.M.'s, have come up with a variety of incentives and penalties to convince doctors and pharmacists to substitute a drug preferred by the P.B.M. for the one originally prescribed. Commercial considerations, especially the financial relationships between the P.B.M.'s and drug manufacturers, are the primary factors in determining which drugs are preferred.", "headline": {"main": "Prescription Switches", "kicker": "In America"}, "abstract": "Bob Herbert column draws attention to potential problems posed by pharmaceutical benefit managers, large and increasingly powerful companies that handle purchase and distribution of prescription drugs for many HMO's and insurance companies; warns that in their zeal to enhance profits, benefit managers, known as PBM's, have come up with variety of incentives and penalties to convince doctors and pharmacists to substitute a drug preferred by PBM for one originally prescribed; points out that commercial considerations, especially financial relationships between PBM's and drug manufacturers, are primary factors in determining which drugs are preferred (M)", "print_page": "39", "word_count": 639, "_id": "4fd1edde8eb7c8105d74081f", "snippet": "Very few consumers of prescription drugs are aware of the existence of pharmaceutical benefit managers, the large and increasingly powerful companies that handle the purchase and distribution of prescription drugs for many H.M.O.'s and insurance...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/12/27/opinion/prescription-switches.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Bob", "lastname": "HERBERT"}], "original": "By BOB HERBERT"}, "document_type": "article", "pub_date": "1996-12-27T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Struggling to limit the effect of recent ballot initiatives in California and Arizona that relax restrictions on the medical use of marijuana and other illegal drugs, Federal officials say they plan to prosecute and strip prescription licenses from doctors who help supply such drugs to even seriously ill people. The officials said that after an intense and sometimes unwieldy debate over the past six weeks about how the Federal Government should respond to the new state laws, the Justice Department has decided against filing suit to try to block either of the measures in court.", "headline": {"main": "Doctors Are Focus of Plan To Fight New Drug Laws"}, "abstract": "Federal officials, struggling to limit effects of recent ballot initiatives in California and Arizona that ease curbs on medical use of marijuana and other illegal drugs, plan to prosecute and strip prescription licenses from doctors who help supply drugs to even seriously ill people; Drug Enforcement Administration head Thomas A Constantine outlines plan, which also involves education effort and prosecution of drug distributors, interview; Justice Department has decided against court challenge (M)", "print_page": "10", "word_count": 1325, "_id": "4fd1fcd18eb7c8105d75c34b", "snippet": "Struggling to limit the effect of recent ballot initiatives in California and Arizona that relax restrictions on the medical use of marijuana and other illegal drugs, Federal officials say they plan to prosecute and strip prescription licenses from...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1996/12/23/us/doctors-are-focus-of-plan-to-fight-new-drug-laws.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CONSTANTINE, THOMAS A"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "glocations", "value": "ARIZONA"}, {"name": "organizations", "value": "DRUG ENFORCEMENT ADMINISTRATION"}, {"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "subject", "value": "LICENSES"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}, {"name": "subject", "value": "MARIJUANA"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tim", "lastname": "GOLDEN"}], "original": "By TIM GOLDEN"}, "document_type": "article", "pub_date": "1996-12-23T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 3, "offset": 0, "time": 42}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}